key: cord-0721521-fuxpyk4y
authors: Oshay, Rachel R.; Chen, Michael Y.C.; Fields, Brandon K.K.; Demirjian, Natalie L.; Lee, Ryan S.; Mosallaei, Daniel; Gholamrezanezhad, Ali
title: COVID-19 in pregnancy: a systematic review of chest CT findings and associated clinical features in 427 patients
date: 2021-01-13
journal: Clin Imaging
DOI: 10.1016/j.clinimag.2021.01.004
sha: fa67c00835d8a8873a0893019578f3dfe1833416
doc_id: 721521
cord_uid: fuxpyk4y

PURPOSE: Our purpose was to conduct a comprehensive systematic review of all existing literature regarding imaging findings on chest CT as well as associated clinical features in pregnant patients diagnosed with COVID-19. MATERIALS & METHODS: A literature search was conducted on April 21, 2020 and updated on July 24, 2020 using PubMed, Embase, World Health Organization, and Google Scholar. Only studies which described chest CT findings of COVID-19 in pregnant patients were included for analysis. RESULTS: A total of 67 articles and 427 pregnant patients were analyzed. The most frequently encountered pulmonary findings on chest CT of pregnant patients diagnosed with COVID-19 were ground-glass opacities (77.2%, 250/324), posterior involvement (72.5%, 50/69), multilobar involvement (71.8%, 239/333), bilateral lung involvement (69.4%, 231/333), peripheral distribution (68.1%, 98/144), and consolidation (40.9%, 94/230). Pregnant patients were also found to present more frequently with consolidation (40.9% vs. 21.0–31.8%) and pleural effusion (30.0% vs. 5.0%). Clinical findings included antepartum fever (198 cases), lymphopenia (128 cases), and neutrophilia (97 cases). Of the 251 neonates delivered to mothers with COVID-19, 96.8% of the neonates had negative RT-PCR and/or IgG antibody testing. In the eight cases (3.2%) of reported neonatal infection, tests were either conducted up to 72 h after birth or were found negative on all subsequent RT-PCR tests. CONCLUSION: Pregnant patients appear to present with more advanced COVID-19 CT findings than those of the general adult population. The changes in laboratory values found in pregnant patients also mirror those found in the general patient population. Lastly, results from neonatal testing suggest low risk of vertical transmission. SUMMARY STATEMENT: The initial chest CT scans of 427 pregnant patients with COVID-19 showed higher rates of consolidation and pleural effusion in comparison to the general population.

On New Year's Eve 2019, Chinese national officials reported an outbreak of a highly-contagious pneumonia of unknown cause in Wuhan, Hubei Province, China to the World Health Organization (WHO) [1] . By mid-February, the WHO named the disease caused by this new coronavirus as COVID-19 [1] . Although data from the WHO suggests that as many as 80% of infections are mild or asymptomatic, common symptoms of COVID-19 include shortness of breath, fever, lethargy, sore throat, fever, headache, chest pain, diarrhea, ageusia, and anosmia [2] . Extra-pulmonary features of the disease include renal, gastrointestinal, liver, cardiac, neurological, and hematological manifestations [3] . Before reverse transcriptase polymerase chain reaction (RT-PCR) test kits became widely available, chest computed tomography (CT) was used in some settings as a tool to confirm diagnoses and to track progression of the disease [4] [5] [6] [7] [8] [9] [10] [11] . The most common features on CT imaging of patients in the general population with COVID-19 are multifocal, patchy, ground-glass opacities (GGOs) with or without superimposed consolidation in a peripheral or posterior distribution [6, 12] .

Pregnant patients are a unique population of interest in the COVID-19 pandemic as they are typically young, otherwise-healthy individuals; however, they also experience an altered immunological state due to their expectancy. In 2003, pregnant patients who contracted SARS were found to be at increased risk for development of spontaneous miscarriage, preterm labor, and maternal death. However, follow-up testing on neonates postnatally was unable to detect serologic evidence of vertical transmission in select cohorts [13] . There are limited data regarding pregnant patients with COVID-19; thus it is not yet known whether or not the disease can be transmitted vertically from mother to fetus [14] .

While guidelines suggest avoidance of ionizing radiation in pregnancy, appropriate shielding and lowdose protocols may allow for relatively safe use of chest CT for situations in which such investigations are clinically indicated [15] . Since much of the existing literature regarding this unique patient population currently remains limited to case reports and case series, the primary purpose of this systematic review standard morphologic descriptors [6, 18, 19] , as seen in Tables 2 and 3 . We found the following trends in Tables 2 and 3 .

Several extra-pulmonary manifestations were also recorded. As many articles tended only to report extrapulmonary/constitutional symptoms and laboratory findings if abnormal, exact proportions were not possible to calculate. However, among a total sample size of 427 patients, 150 patients were reported to have elevated CRP, 128 patients with lymphopenia, 97 patients with neutrophilia, 73 patients with leukocytosis, 51 patients with elevated D-dimers, 24 patients with decreased hemoglobin, and 24 patients with elevated procalcitonin. Likewise, a total of 198 patients had documented fevers prior to delivery (antepartum) and 67 had fevers in the postpartum period. Additionally, 15 patients had gastrointestinal involvement/diarrhea and 12 patients had cardiac involvement. Of those who experienced cardiac complications, a total of eight patients succumbed to cardiac arrest and were unable to be resuscitated.

Three of these fatal cases were attributed to refractory hypotension, including one patient who experienced a severe heart failure with an ejection fracture of 10 -15% and another patient who experienced left-sided heart failure with an ejection fraction of 25% [20] [21] [22] . In addition, one patient was found to have nonfatal pericardial effusion [23] (Table 4 ). 

In the era of COVID-19, pregnant patients pose as a uniquely susceptible and understudied population.

While routine exposure to ionizing radiation is discouraged during pregnancy, current guidelines recommend that chest CT should not be withheld when clinically indicated, as the radiation dose from a single scan remains sub-threshold to cause teratogenic effects when appropriate precautions are taken [24] [25] [26] . At the beginning of the COVID-19 pandemic, chest CT scans were frequently used in many patients [9] [10] [11] , including those who were pregnant. As knowledge of the disease became more disseminated and RT-PCR testing kits were made more readily available, chest CT use has since been In a systematic review of 919 adult patients with COVID-19, Salehi et al. found that 87.5% of patients had evidence of bilateral involvement, 76.0% had evidence of peripheral distribution, and 80.4% had evidence of posterior involvement [6] . Furthermore, 88.0% of their patients displayed GGOs and 31.8% displayed consolidation [6] . Similarly, Liu et al. identified bilateral involvement in 79% of their nonpregnant patients, but only 21% of them showed evidence of consolidation [27] . Compared with our results, these findings suggest that pregnant patients may have a slightly lower prevalence of bilateral involvement of COVID-19 disease than the general population (69.4% vs. 79 -87.5%), which is consistent with data suggesting lower rates of bilateral disease in younger populations [28] . Additionally, our results suggest that pregnant patients may have lower rates of GGOs (77.2% vs. 88.0%) and higher rates of consolidation compared to the general population (40.9% vs. 21.0 -31.8%). These comparisons are further detailed in Table 5 . Also of note, pregnant patients were found to have a higher rate of pleural effusion when compared to that of the general population (30.0% vs 5.0%) [29] . Currently, limited data exists on the prevalence of pleural effusion in pregnancy. Though pregnancy is a known risk factor for pleural effusion, our results still suggest a 3-fold higher prevalence of pleural effusion when compared to preliminary observational data taken from an asymptomatic pregnant cohort [30, 31] . Considering that consolidation and pleural effusion are indicative of more severe disease, our results suggest that pregnant patients may be more prone to presentation at advanced disease stages [32] .

One theory as to why pregnant patients may be more susceptible to severe progression of COVID-19 is that they experience thoracic cage splaying and reduced functional residual capacity due to the expansive volume of the gravid uterus [32, 33] . In a study comparing pregnant and non-pregnant patients with SARS, two-thirds of the pregnancy-related deaths occurred in patients during their second or third J o u r n a l P r e -p r o o f Journal Pre-proof trimester, at the time when these physiological changes are most evident [33] . These same changes could increase a patient's risk of developing severe complications of COVID-19 by reducing the ability to clear secretions, leading to a higher likelihood of developing consolidative pneumonia. Another theory is that altered immune functionality during pregnancy predisposes patients to acute pulmonary injury [33, 34] .

This could explain the fewer instances of GGOs and greater instances of consolidation. The lungs of these particularly susceptible patients could be compensating with more inflammation, and as a result, the GGOs appear to have consolidated when viewed via CT imaging. Furthermore, most fatal cases in our cohort resulted from cardiac complications with low ejection fraction. Pregnancy is in and of itself is a known risk factor for cardiomyopathy; however, experienced as myocardial injury is now also a known manifestation of COVID-19, it is possible that additive effects of disease may not just be limited to pulmonary manifestations and may in fact extend to other organ systems [3, 35] .

Of note, 150 patients in our patient population were reported to have presented with elevated CRP levels (>10 mg/L), and 24 were noted to have presented with elevated procalcitonin levels (>0.1 ng/mL). A small meta-analysis previously found that an increase in procalcitonin was correlated with advanced progression of COVID-19 by nearly fivefold [36] ; however, only 2 of the 24 patients with elevated procalcitonin levels in our review required mechanical ventilation, and 23 patients recovered fully. In addition, 51 patients exhibited elevated D-dimer values of ≥2.0 µg/mL. While an elevated D-dimer value has been associated with a greater morbidity and mortality in COVID-19 [37] [38] [39] [40] [41] , all 51 patients with elevated D-dimer levels in our study population made a complete recovery. As physiological pregnancy is in and of itself associated with an elevated D-dimer measurement and procoagulability, the implications of elevated D-dimer levels in this clinical context remain unclear [42] . Although there are existing correlations amongst elevated D-dimer values, pregnancy, and the occurrence of thrombotic events [42] , only one out of the 427 patients in this review reported a pulmonary embolism. On admission, this patient's D-dimer value was 16.4 µg/mL, and the small segmental pulmonary embolism J o u r n a l P r e -p r o o f Journal Pre-proof was detected on hospital day 7 via CT scan. The 17-year-old patient had a successful emergent C-section, and both mother and neonate were later discharged [43] .

Of those measured, 128 patients had lymphopenia and 97 patients had neutrophilia. When compared to what is known for standard COVID-19 patients, we can see lymphopenia and/or neutrophilia are typical features of presentation [44] . However, Wei et al. found the extent of lymphopenia and neutrophilia in the pregnant population to be much higher compared to the general population [45] . Some authors have suggested that these findings may be indicative of a defective immune response in the setting of a hyperinflammatory state, which may coincide with a greater risk for severe progression in this patient population. When looking other historical coronaviruses, similar trends of lymphopenia and/or neutrophilia were observed with both SARS and MERS [44, 46, 47] .

Of the 298 mothers who gave birth during admission, we found a preterm birth rate of 28.0%. A study comparing pregnancy outcomes among SARS, MERS, and COVID-19 showed that these three diseases had associated preterm birth rates of 15.03%, 0%, and 41.11% [48] . The values reported by Tang et al. and in our study suggest that COVID-19 may lead to a higher preterm birth rate than other forms of viral pneumonia when compared with global preterm birth rates of 12% and 9% in underdeveloped and developed countries, respectively [49] . Further investigation is needed to better characterize these risks and associated causalities.

Lastly, a primary concern when studying viral infections in pregnant patients is vertical transmission.

Maternal-fetal transmission was not observed with other coronavirus epidemics, including SARS and MERS. As more literature regarding COVID-19 becomes available, there is a growing body of literature to suggest that the risk of vertical transmission with COVID-19 remains similarly negligible [50] . We found that 96.8% of patients in our data set showed no signs of vertical transmission at delivery. In the eight cases (3.2%) in which neonatal infection was reported, six of the eight diagnoses were due to J o u r n a l P r e -p r o o f Journal Pre-proof positive RT-PCR tests. However, as testing was performed on samples collected up to 72 hours postpartum, the possibility of extrauterine exposure cannot be ruled out. One such example was shown in Mehta et al., a case series that reported delivery of a pair of fraternal twins in which only one of the two neonates tested positive for COVID-19 by RT-PCR [51] . As viral transmission to only one of the two neonates in the shared intrauterine environment would seem unlikely, a more plausible explanation is that Twin A may have been infected during the 72-hour postpartum period prior to sample collection. In addition, the remaining two cases were reported as positive due to positive IgG tests conducted 2 hours postpartum. Since IgG antibodies can be transmitted across the placenta, it is possible that the IgG antibodies detected in the neonates' blood were of maternal origin. This hypothesis was supported by negative test results upon all subsequent RT-PCR tests, in both cases.

There were several factors that limited our study. First, as the findings from this systematic review were aggregated primarily from case reports and case series, we acknowledge a risk of sampling bias in that such reports often tend to skew toward only reporting positive findings. Second, many of the articles included in this systematic review did not adhere to a standardized lexicon to describe the chest CT findings of COVID-19. As a result, many of the reported imaging findings required investigator interpretation for appropriate classification using standard morphologic descriptors. For this reason, we argue in favor of adopting a common lexicon for describing COVID-19-associated features, as described by Salehi et al. [18] . Use of a standardized reporting system will improve both patient care and future Lastly, despite an increased rate of prematurity as compared to the world preterm birth rate, we do not observe frequent vertical transmission of COVID-19 infection. While our results suggest more advanced presentations than would be otherwise expected for age and gender, further study is needed to more definitively quantify our findings against historical controls. Table 2 -The denominators for each imaging finding included only those patients for whom the presence or absence of a given finding could be definitely evaluated. Any patients without any details regarding the given feature were excluded from the denominator. Table 3 -Opacities NOS = Opacities not otherwise specified. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f Journal Pre-proof Figure 1 

COVID-19) -events as they happen. World Health Organ Website

COVID-19) Situation Report 46. World Health Organ Website

Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview

Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR

Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients

Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation Service

COVID-19) pandemic on healthcare workers: A nationwide survey of United States radiologists

Role of Chest CT in Resource-Driven

diagnostic technologies: A country-based retrospective analysis of screening and containment procedures during the first wave of the pandemic

Early Clinical and CT Manifestations of

COVID-19) Pneumonia

Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

What We Know and Don't Know About Coronavirus and Pregnancy. What We Know Don't

Know Coronavirus Pregnancy UC San Franc 2020

Assessment Tool for Case Series Studies. NIH Natl Heart Lung Blood Inst Website n

Pregnancy and Laboratory Studies: A Reference Table for Clinicians

imaging reporting and data system (COVID-RADS) and common lexicon: a proposal based on the imaging data of 37 studies

Fleischner Society: glossary of terms for thoracic imaging

Twin pregnant woman with COVID-19: a case report

A mortal case of coronavirus disease in a pregnant diabetic woman

Maternal death due to COVID-19

COVID-19 is a risk factor for severe liver damage for patients with intrahepatic cholestasis of pregnancy: a case report

Coronavirus (COVID-19) and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know

Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel

ACOG Committee Opinion: Guidelines for

Diagnostic Imaging During Pregnancy and Lactation

Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children

Imaging Findings of SARS-CoV-2

Infection in Pediatrics: A Systematic Review of Coronavirus Disease 2019 (COVID-19) in 850 Patients

CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients

Pleural Diseases in Pregnancy: Aetiology and Management

The Prevalence of Pleural Effusion in Pregnant Women: A Pilot Study

Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review

A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome

Acute respiratory failure in pregnancy

Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation

A meta-analysis

Coronavirus disease 2019 (COVID-19): an update on neurologic sequelae

Pneumonia and pregnancy

D-dimer levels on admission to predict inhospital mortality in patients with Covid-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Dimer Concentrations in Normal Pregnancy: New Diagnostic Thresholds Are Needed

Pulmonary embolism in a young pregnant woman with COVID-19

COVID-19 and the clinical hematology laboratory

Clinical characteristics and outcomes between pregnant and non-pregnant women with Coronavirus disease 2019: a retrospective cohort study

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics

Characteristics and pregnancy outcomes of patients with severe pneumonia complicating pregnancy: a retrospective study of 12 cases and a literature review

COVID-19) from Infected Pregnant Mothers to Neonates: A Review

Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: A case report

A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery

A case report of neonatal COVID-19 infection in China

A mortal case of coronavirus disease in a pregnant diabetic woman

A patient with SARS-CoV-2 infection during pregnancy in Qingdao

Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran

Anesthesia and protection in an emergency cesarean section for pregnant woman infected with a novel coronavirus: case report and literature review

Anesthetic Management for Emergent Cesarean Delivery in a Parturient with Recent Diagnosis of Coronavirus Disease 2019 (COVID-19): A Case Report

Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission

Care of the pregnant woman with coronavirus disease 2019 in labor and delivery: anesthesia, emergency cesarean delivery, differential diagnosis in the acutely ill parturient, care of the newborn, and protection of the healthcare personnel

Chest computed tomography images of early coronavirus disease

Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia

Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia

Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: A retrospective study

Clinical and Imaging Features of COVID-19 in a

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical

Clinical characteristics and risk assessment of newborns born to mothers with COVID-19

Clinical characteristics of 19 neonates born to mothers with COVID-19

Clinical Characteristics of Pregnant Women with Coronavirus Disease

Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study

Clinical Features of Pregnant Women and Neonates with COVID-19 in Wuhan: a paired comparison study 2020

Clinical Manifestation and Neonatal Outcomes of Pregnant Patients With Coronavirus Disease

Clinical presentations and outcomes of SARS

CoV-2 infected pneumonia in pregnant women and health status of their neonates

Clinico-Radiological Features and Outcomes in Pregnant Women with COVID-19: Compared with Age-Matched Non-Pregnant Women

Coronavirus disease 2019 (COVID-19) in pregnancy: 2 case reports on maternal and neonatal outcomes in Yichang city

COVID-19 as a trigger of acute chest syndrome in a pregnant woman with sickle cell anemia

COVID-19 infection during the third trimester of pregnancy: Current clinical dilemmas

CT characteristics and diagnostic value of COVID-19 in pregnancy

Emergency Caesarean delivery in a patient with confirmed COVID-19 under spinal anaesthesia

Emergency cesarean section on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed patient

False-Negative COVID-19 Testing: Considerations in Obstetrical Care

Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth

Infants Born to Mothers With a New Coronavirus (COVID-19)

Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19

Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19

Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series

Mechanical Ventilation in Pregnancy Due to COVID-19: A Cohort of Three Cases

No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy

Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: A case report

Obstetric and intensive-care strategies in a high-risk pregnancy with critical respiratory failure due to COVID-19: A case report

Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report

Perinatal outcomes in critically ill pregnant women with coronavirus disease 2019

Should We Worry? Clin Infect Dis 2020

Possible formation of pulmonary microthrombi in the early puerperium of pregnant women critically ill with COVID-19: Two case reports

Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women

Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis

Preterm delivery in pregnant woman with critical COVID-19 pneumonia and vertical transmission

Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia

Report of a series of healthy term newborns from convalescent mothers with COVID-19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection during late pregnancy: A Report of 18 patients from Wuhan

Severe coronavirus infection in pregnancy: challenging cases report

during Pregnancy and Possible Vertical Transmission

Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection

Unfavorable outcomes in pregnant patients with COVID-19

Unlikely SARS-CoV-2 vertical transmission from mother to child: A case report

Update on clinical outcomes of women with COVID-19 during pregnancy